Acasti Pharma, Inc. - (ACST) Social Stream
ACASTI PHARMA INC (ACST) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACST.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-22 | 1 | $6 | $6 | $6 | $0.539 | 1013.17% |
| 2022-06-22 | 1 | $5 | $5 | $5 | $0.539 | 827.64% |
| 2022-11-16 | 1 | $2 | $2 | $2 | $0.539 | 271.06% |
| 2022-12-15 | 2 | $2.4 | $2 | $2.2 | $0.539 | 308.16% |
| 2023-05-09 | 3 | $2.5 | $2 | $2.3 | $0.539 | 326.72% |
Price Target Last Issued June 22, 2022
The Trend in the Analyst Price Target
ACST's average price target has moved up $2.05 over the prior 23 months.
ACST reports an average of 379.74% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-22 | 1 | 5.0 | 5 | 5.0 | 0.901 | 454.94% |
| 2022-11-16 | 1 | 2.0 | 2 | 2.0 | 0.450 | 344.44% |
| 2022-12-15 | 2 | 2.4 | 2 | 2.2 | 0.352 | 525% |
| 2023-02-16 | 3 | 2.5 | 2 | 2.3 | 0.637 | 261.07% |
| 2023-05-09 | 3 | 2.5 | 2 | 2.3 | 0.480 | 379.17% |
ACST Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ACST's average broker recommendation rating improved by 0 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACST as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ACASTI PHARMA INC's number of analysts covering the stock is greater than 11.59% of them.
- In terms of how ACASTI PHARMA INC fares relative to all US stocks, note that its average analyst price target is greater than 11.74% of that group.
- In terms of how ACASTI PHARMA INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 80.46% of that group.
- In terms of how ACASTI PHARMA INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 396.35% of that group.
In the Pharmaceutical Products industry, VBLT, CANF, and BLRX are the three stocks most similar to ACASTI PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ACST a Buy, Hold or Sell? See the POWR Ratings now!